|
US2009292022A1
|
|
Method of treating post-surgical acute pain
|
|
US2008057122A1
|
|
Acetaminophen pharmaceutical compositions
|
|
WO2006023714A2
|
|
Dithiocarbamate derivatives and their use for treating cancer
|
|
US2005267159A1
|
|
Magnesium complexes of S-omeprazole
|
|
WO2005086960A2
|
|
Narcotic-nsaid ion pairs
|
|
WO2005020984A2
|
|
Method of reducing the risk of oxidative stress
|
|
AU2003203901B2
|
|
Oral liquid compositions
|
|
AU2002322456A1
|
|
Polymorphic forms of 6-(4-(1-cyclohexyl-1h-tetrazol-5-yl)butoxy)-3, 4-dihydro-2(1h)-quinolinone
|
|
WO03002120A1
|
|
Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetrazol-5-yl)butoxy]-3, 4-dihydro-2(1h)-quinolinone
|
|
WO03002121A1
|
|
Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetrazol-5-yl)butoxy]-3, 4-dihydro-2(1h)-quinolinone
|
|
CA2443605A1
|
|
Process for purifying 6-methoxy omeprazole
|
|
WO02060857A1
|
|
Form a of fluoxetine hydrochloride
|
|
EP1595879A2
|
|
Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
|
|
BR0014145A
|
|
Benzimidazole compounds substituted by alkoxy, pharmaceutical preparations containing the same, and methods of using the same
|
|
UA80085C2
|
|
Oral liquid compositions
|
|
UA27850C2
|
|
EXTINGUISHER
|
